510(k) device
Vivally System Wearable
Avation Medical, Inc. · Stimulator, Peripheral Nerve, Non-Implanted, For Urinary Incontinence (NAM, Class II) · First FDA decision Apr 3, 2023, newest Apr 3, 2023Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Vivally"
MAUDE reports
0
Brand "Vivally", since 2015
PubMed studies
1
Mentioning "Vivally"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vivally System Wearable
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K220454 · Decided Apr 3, 2023 · 410 days after receipt
Device type: Stimulator, Peripheral Nerve, Non-Implanted, For Urinary Incontinence (NAM) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Sacral Nerve Stimulation For Urinary IncontinenceNational determinationOn the books230.18Updated Dec 8, 2025
- Sacral Nerve Stimulation for the Treatment of Urinary and Fecal IncontinenceLocal determinationIn effectL39543Palmetto GBAUpdated Sep 12, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Home Biofeedback For Urinary IncontinenceNational analysisReview closedCAG-00118NUpdated Sep 14, 2026
- Biofeedback for Urinary IncontinenceNational analysisReview closedCAG-00020NUpdated Sep 14, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vivally", any status and sponsor, newest update first.
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT06661057 · 0 participants · Start Dec 1, 2024 · Primary completion Nov 30, 2026
Device: Vivally system stimulation · For: Neurogenic Bladder
- Real-World Registry - The Vivally® SystemEnrolling by invitation
Avation Medical, Inc.Not on our public-company list
NCT06085846 · 5,000 participants (planned) · Start Jul 14, 2023 · Primary completion Jul 1, 2043
Device: Vivally® System Wearable, Non-Invasive Neuromodulation System, and Mobile Application · For: Urinary Incontinence; Urinary Urge Incontinence
Sites: Columbus, Ohio
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vivally", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NAM
92 reports: 2 malfunction, 88 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vivally"[tiab]. The summary above synthesizes these.
- A Multicenter Prospective Sham-controlled Trial Evaluating a Physiologic Closed-loop Wearable Tibial Neuromodulation System for Overactive Bladder.
Goudelocke C, Dhir R, Shapiro E, et al. · Urology · 2025Multicenter Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code NAM.
- Urgent Pc Neuromodulation System, Models UPC200 and UPC250-12Uroplasty, Inc. · 510(k) 2007
- ZIDA Wearable Neuromodulation SystemExodus Innovations · 510(k) 2021
- Nuro Neuromodulation SystemAdvanced Uro-Solutions, Inc. · 510(k) 2013
- Urgent Pc StimulatorUroplasty, Inc. · 510(k) 2010
- Urosurge Percutaneous Sans (Stoller Afferent Nerve Stimulator) DeviceUrosurge, Inc. · De Novo 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.